HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2. The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, oral mucositis, nonalcoholic steatohepatitis, diabetic macular edema, and dry eye indications. The company was formerly known as GenoFocus, Inc. HLB Genex, Inc. was founded in 2000 and is based in Daejeon, South Korea.
Metrics to compare | 187420 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship187420PeersSector | |
---|---|---|---|---|
P/E Ratio | −4.9x | 7.1x | 2.2x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 4.1x | 1.1x | 1.6x | |
Price / LTM Sales | 2.3x | 1.0x | 1.3x | |
Upside (Analyst Target) | - | 0.0% | 20.4% | |
Fair Value Upside | Unlock | 13.9% | 1.1% | Unlock |